I
INVO Fertility, Inc. (IVF)
NCM – Real vaqt narxi. Valyuta: USD
1.58
-0.03 (-2.16%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.62
+0.03 (2.21%)
Bozordan keyin: May 12, 2026, 7:57 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.58
-0.03 (-2.16%)
Yopilishda: May 12, 2026, 4:00 PM EDT
1.62
+0.03 (2.21%)
Bozordan keyin: May 12, 2026, 7:57 PM EDT
INVO Fertility, Inc., sog'liqni saqlash xizmatlari kompaniyasi, bemorlarga yordamchi reproduktiv texnologiya (ART) yordamida davolashni ta'minlaydigan reproduktiv texnologiya bozoriga qaratilgan. U Fertility Clinic Services; INVOcell Device; va Therapeutics segmentlari orqali faoliyat yuritadi. Kompaniya INVOcell Device-ni taklif etadi, bu tibbiy moslama bo'lib, u urug'lanish va embrionning dastlabki rivojlanishini ayol tanasida in vivo joylashishiga imkon beradi. U, shuningdek, INVO Centers kabi reproduktiv klinikalarni boshqaradi. Bundan tashqari, kompaniya gepatotsellyulyar karsinomani davolash uchun I/II fazali monoterapiya sinovida bo'lgan GPC3 x NKp46 bifunksional antitelasi bo'lgan NY-303; va AI-optimallashtirilgan bifunksional antitelasi bo'lgan NY-500ni ishlab chiqadi. Kompaniya ilgari NAYA Biosciences, Inc. nomi bilan tanilgan va 2025-yil aprel oyida INVO Fertility, Inc. nomini olgan. INVO Fertility, Inc. 2007-yilda tashkil etilgan va Florida shtatining Sarasota shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Andrea Goren | Chief Business Officer |
| Mr. Steven M. Shum | CEO & Director |
| Ms. Terah Krigsvold | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-29 | 8-K | form8-k.htm |
| 2026-04-01 | NT 10-K | formnt10-k.htm |
| 2026-03-31 | 8-K | form8-k.htm |
| 2026-02-24 | 8-K | form8-k.htm |
| 2026-02-06 | S-8 | forms-8.htm |
| 2026-02-06 | CORRESP | filename1.htm |
| 2026-02-02 | S-1 | forms-1.htm |
| 2026-01-30 | 8-K | form8-k.htm |
| 2026-01-26 | 8-K | form8-k.htm |
| 2026-01-06 | 8-K | form8-k.htm |